×

Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma

  • US 20030021781A1
  • Filed: 07/17/2001
  • Published: 01/30/2003
  • Est. Priority Date: 11/13/1992
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for the treatment of B cell lymphoma comprising the step of administering a therapeutically effective amount of at least one immunologically active, chimeric anti-CD20 antibody to a human.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×